Skip to main content
SpringerLink
Log in

Adalimumab

Immune-mediated skin reactions: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Vorcakova K, et al. Anti-TNF alpha-induced immune-mediated skin adverse reactions resolved by switching to ustekinumab. [Croatian]. Gastroenterologie a Hepatologie 73: 496-500, No. 6, Jan 2019. Available from: URL: http://doi.org/10.14735/AMGH2019496 [Slovakian; summarised from a translation]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1810, 15 (2020). https://doi.org/10.1007/s40278-020-80035-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80035-5

Search

Navigation